Study of Marine Compounds as Potential Anti-Tuberculosis Agents
Author Information
Author(s): MASYITA Ayu, SEPTIANA Eris, BAYU Asep, BUSTANUSSALAM Bustanussalam, PANGGABEAN Jonathan A., FIRDAYANI Firdayani, MURNIASIH Tutik
Primary Institution: Research Center for Vaccine and Drugs, Research Organization for Health, National Research and Innovation Agency (BRIN), Cibinong, Bogor, Indonesia
Hypothesis
Can bioactive compounds derived from Indonesian marine invertebrates serve as novel antituberculosis agents?
Conclusion
The study found that psammaplysin groups have potential as anti-TB compounds, warranting further laboratory experiments.
Supporting Evidence
- 19-hydroxypsammaplysin Q showed the lowest docking score against MtPanK.
- 19-hydroxypsammaplysin S had the strongest activity against Mtb InhA.
- Psammaplysin L was more potent compared to commercial drugs against MtPknB.
- Psammaplysin K dimethoxy acetal had a favorable docking score against MtKasA.
Takeaway
Scientists are looking at special substances from sea animals to see if they can help fight tuberculosis, a serious disease.
Methodology
The study used in silico molecular docking to screen compounds derived from marine invertebrates against specific proteins of Mycobacterium tuberculosis.
Limitations
The study is based on computational predictions and requires laboratory validation.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website